No, 2026 Medicare Part D changes will not swallow the typical Social Security COLA, the yearly inflation adjustment to benefits. Medicare Part D, the prescription-drug coverage, raised its spending cap and deductible only modestly for 2026. The Social Security Administration says in its 2026 COLA fact sheet that the 2.8% COLA adds about $56 per month to the average retired-worker check. That gain faces a $17.90 rise in the standard Part B premium, which the Centers for Medicare & Medicaid Services announced in its 2026 premiums fact sheet.
Official resources:
- Register through Medicare’s official page — Use this page to review requirements and register directly.
- Read the official guidance from CMS — Use this primary source to verify the official guidance.
Table of Contents
- Where does the COLA go first?
- What changed in Part D for 2026?
- Who feels the pinch most?
- How can you keep more of the increase?
Where does the COLA go first?
The Part B premium takes the first bite. Subtract $17.90 from the average $56 gain and about $38 remains before drug-plan premiums and cost sharing. AARP's analysis of the same agency figures reaches the same one-third result. The hold-harmless rule adds a floor, not a shield.
AARP explains that the rule stops a standard Part B increase from cutting most beneficiaries' net checks. It caps only Part B, so a small benefit increase can still shrink to a few dollars. The Part B deductible also rises. The 2026 deductible is $283, and people who use care early in the year will meet it from savings or monthly cash flow.
What changed in Part D for 2026?
Medicare.gov states in its Part D costs page that out-of-pocket spending on covered drugs is capped at $2,100 in 2026, up from $2,000. Once enrollees reach that limit, they pay $0 for covered drugs for the rest of the year. The same Medicare.gov page sets the maximum Part D deductible at $615, up from $590.
Enrollees pay 25% coinsurance after the deductible until they hit the $2,100 limit. KFF reports in its drug negotiation explainer that Maximum Fair Prices for the first 10 negotiated Part D drugs took effect Jan. 1, 2026. The list includes Eliquis, Jardiance, Xarelto and Januvia.
📨 Get Free Medicare Guides Alerts
Free · No spam · Unsubscribe anytime
Who feels the pinch most?
People with below-average benefits feel it most. A 2.8% raise on a smaller check leaves fewer dollars after the flat $17.90 Part B increase. High Part B use plus the higher Part B deductible can tighten the first months. High drug users face a mixed result.
The $100 rise in the out-of-pocket cap and the $25 rise in the maximum deductible add up to $125 in possible added exposure. That equals a little more than two months of the average $56 COLA gain, spread across a year. Lower drug users may notice little change. Someone who fills one low-cost generic may never approach the deductible or the cap. The limit helps most when covered-drug spending is high and steady.
How can you keep more of the increase?
Start with your own drug list, not the average. Averages hide wide gaps between low-cost and high-cost prescriptions.
If you take one of the 10 negotiated drugs, ask your plan how the new price flows into your cost share. Compare your drug list against your plan's covered-drug list before you renew.
- List every prescription, dose, and pharmacy you use.
- Check whether each drug is covered and what tier it sits on.
- Compare the deductible, coinsurance, and pharmacy rules for plans open to you.
- Track covered-drug spending toward the $2,100 cap during the year.
You Might Also Like
- What Will the 2027 Social Security COLA Mean for Medicare Premiums?
- What Is the Downside of a Larger Social Security COLA?
- When Does Social Security Mail COLA Notices to Retirees?